929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

tirzepatide 12.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices

tirzepatide 12.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices

tirzepatide 15 mg/0.5 mL injection, 2 x 0.5 mL pen devices

tirzepatide 15 mg/0.5 mL injection, 4 x 0.5 mL pen devices

tirzepatide 2.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices

tirzepatide 2.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices

tirzepatide 5 mg/0.5 mL injection, 2 x 0.5 mL pen devices

tirzepatide 5 mg/0.5 mL injection, 4 x 0.5 mL pen devices

tirzepatide 7.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices

tirzepatide 7.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices

titanium dioxide 8.5% cream, 75 g

titanium dioxide 9.8% + zinc oxide 2% cream, 200 g

titanium dioxide 9.8% + zinc oxide 2% cream, 75 g

titanium dioxide 9.8% + zinc oxide 2% lotion, 200 g

titanium dioxide 9.8% + zinc oxide 2% lotion, 75 g

tobramycin 20 mg/2 mL injection, 5 x 2 mL vials

tobramycin 28 mg powder for inhalation, 224 capsules

tobramycin 28 mg powder for inhalation, 56 capsules

tobramycin 0.3% eye ointment, 3.5 g

tobramycin 0.3% eye drops, 5 mL

tobramycin 300 mg/5 mL inhalation solution, 4 x 5 mL ampoules

tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules

tobramycin 300 mg/5 mL inhalation solution, 8 x 5 mL ampoules

tobramycin 500 mg/5 mL injection, 10 x 5 mL vials

tobramycin 80 mg/2 mL injection, 2 mL vial

tobramycin 80 mg/2 mL injection, 10 x 2 mL vials

tobramycin 80 mg/2 mL injection, 5 x 2 mL ampoules

tobramycin 80 mg/2 mL injection, 5 x 2 mL vials

tocilizumab 162 mg/0.9 mL injection, 0.9 mL pen device

tocilizumab 162 mg/0.9 mL injection, 0.9 mL syringe

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes

tocilizumab 200 mg/10 mL injection, 10 mL vial

tocilizumab 200 mg/10 mL injection, 4 x 10 mL vials

tocilizumab 400 mg/20 mL injection, 20 mL vial

tocilizumab 400 mg/20 mL injection, 4 x 20 mL vials

tocilizumab 80 mg/4 mL injection, 4 mL vial

tocilizumab 80 mg/4 mL injection, 4 x 4 mL vials

tofacitinib 10 mg tablet, 14

tofacitinib 10 mg tablet, 56

tofacitinib 11 mg modified release tablet, 14

tofacitinib 11 mg modified release tablet, 28

tofacitinib 11 mg modified release tablet, 30

tofacitinib 11 mg modified release tablet, 7

tofacitinib 5 mg tablet, 14

tofacitinib 5 mg tablet, 180

tofacitinib 5 mg tablet, 56

tofacitinib 5 mg tablet, 60

tolnaftate 1% cream, 20 g

tolnaftate 1% cream, 30 g

tolnaftate 1% ointment, 15 g

tolnaftate 10 mg / 1 g powder, 20 g (medicinal product pack)

tolnaftate 1% powder, 60 g

tolnaftate 1% lotion, 10 mL

tolnaftate 0.07% spray, 100 g

tolnaftate 700 microgram / 1 g spray, 125 g (medicinal product pack)

tolnaftate 0.09% (900 microgram/g) spray, 100 g

tolnaftate 0.09% (920 microgram/g) spray, 125 g

tolterodine tartrate 1 mg tablet, 14

tolterodine tartrate 1 mg tablet, 140

tolterodine tartrate 1 mg tablet, 28

tolterodine tartrate 1 mg tablet, 56

tolterodine tartrate 2 mg tablet, 14

tolterodine tartrate 2 mg tablet, 140

tolterodine tartrate 2 mg tablet, 28

tolterodine tartrate 2 mg tablet, 56

tolvaptan 15 mg tablet, 10

tolvaptan 15 mg tablet, 28

tolvaptan 15 mg tablet, 7

tolvaptan 30 mg tablet, 10

tolvaptan 30 mg tablet, 28

tolvaptan 30 mg tablet, 7

tolvaptan 15 mg tablet [28] (&) tolvaptan 45 mg tablet [28], 56

tolvaptan 30 mg tablet [28] (&) tolvaptan 60 mg tablet [28], 56

tolvaptan 30 mg tablet [28] (&) tolvaptan 90 mg tablet [28], 56

topiramate 100 mg tablet, 60 tablets (medicinal product pack)

topiramate 15 mg capsule, 60

topiramate 200 mg tablet, 60

topiramate 25 mg capsule, 60

topiramate 25 mg tablet, 20

topiramate 25 mg tablet, 60

topiramate 50 mg capsule, 60

topiramate 50 mg tablet, 30

topiramate 50 mg tablet, 60

topotecan 1 mg injection, 1 vial

topotecan 1 mg injection, 5 x 1 mg vials (medicinal product pack)

topotecan 4 mg/4 mL injection, 4 mL vial

topotecan 4 mg/4 mL injection, 5 x 4 mL vials

topotecan 4 mg injection, 1 vial

topotecan 4 mg injection, 5 vials

toremifene 60 mg tablet, 10

toremifene 60 mg tablet, 100

toremifene 60 mg tablet, 120

toremifene 60 mg tablet, 15

toremifene 60 mg tablet, 30

toremifene 60 mg tablet, 5

toremifene 60 mg tablet, 60

toremifene 60 mg tablet, 7

toremifene 60 mg tablet, 90

tozinameran 30 microgram/0.3 mL injection, 10 x 2.25 mL vials

tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials

Start Previous Page 153 of 160 Next End

Reference Sets

Reference set descriptor